Recombinant Human TOP2 Protein，His

The study of topoisomerase II (TOP2) proteins has gained significant attention in the field of molecular biology and cancer research due to their essential roles in DNA topology maintenance during cellular processes such as replication, transcription, and chromosome segregation. TOP2 proteins exist as two isoforms, TOP2α and TOP2β, each exhibiting distinct functions and expression patterns across various tissues. TOP2α is predominantly expressed in proliferating tissues and is crucial for cell division, making it a key target in cancer therapies, especially for hematological malignancies and solid tumors. In contrast, TOP2β is more widely distributed and plays a role in transcription regulation and maintaining genomic stability. The inhibition of TOP2 activity, often achieved through the use of certain chemotherapeutic agents like anthracyclines, leads to the formation of DNA double-strand breaks, which ultimately triggers apoptosis in rapidly dividing cancer cells. However, the dual roles of TOP2 proteins in normal and cancerous cells highlight the importance of understanding their mechanisms thoroughly, as this knowledge can lead to the development of more targeted and effective therapies with fewer side effects. Consequently, ongoing research aims to elucidate the structural, functional, and regulatory aspects of TOP2 proteins, providing insights into their potential as therapeutic targets and advancing our comprehension of the complexities of cancer biology.